DOCSLIB.ORG

Annual Report 2008 / Ed

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Report 2008 / Ed 2008 EUR O TRANSPLANT INTER N A TIO N AL FOUN D A TION A n n u a l R e p o r t 2 0 0 8 63082 om 2005 29-06-2006 13:40 Pagina 1 2008 Edited by Arie Oosterlee and Axel Rahmel Eurotransplant Aims Eurotransplant mission statement Mission Service organization for transplant candidates through the collaborating transplant programs within the organization. Goals • To achieve an optimal use of available donor organs and tissues • To secure a transparent and objective selection system, based upon medical and ethical criteria • To assess the importance of factors which have the greatest influence on waiting list mortality and transplant results • To support donor procurement to increase the supply of donor organs and tissues • To further improve the results of transplantation through scientific research and to publish and present these results • Promotion, support and coordination of organ donation and transplantation in the broadest sense of terms CIP-GEGEVENS KONINKLIJKE BIBLIOTHEEK, DEN HAAG Annual Report/Eurotransplant International Foundation.–Leiden: Eurotransplant Foundation. -III., graf., tab. Published annually Annual report 2008 / ed. by Arie Oosterlee and Axel Rahmel ISBN-13: 978-90-71658-28-0 Keyword: Eurotransplant Foundation; annual reports. 2 Table of contents - Board of Eurotransplant International Foundation 5 - TRANSPLANT PROGRAMS AND THEIR DELEGATES IN 2008 6 - Renal programs 6 - Heart programs 7 - Lung programs 8 - Liver programs 9 - Pancreas (islet) programs 10 - Tissue typing laboratories 11 - Foreword 13 1. Report of the Board and the central office of 14 Stichting Eurotransplant International Foundation 1.1 General 14 1.2 Policy 17 1.3 Quality Assurance & Safety 19 1.4 Advisory Committees 20 1.5 Recommendations approved 23 2. Eurotransplant: donation, waiting lists and transplants 26 - Introduction 26 Table 2.1 Number of deceased organ donors used for a transplant, by country of origin, from 2004 to 2008 26 Table 2.2(i) Number of deceased organ donors used for a transplant, by organ, from 2004 to 2008 27 Table 2.2(ii) Number of deceased organ donors used for a transplant, by organ and donor country, in 2008 27 Table 2.3(i) Demographic data on deceased organ donors, used for a transplant, from 2004 to 2008 27 Table 2.3(ii) Demographic data on deceased organ donors, used for a transplant, in 2008 28 Table 2.4a(i) Number of donors, used in a transplant, by type of donor, from 2004 to 2008 28 Table 2.4a(ii) Number of donors, used in a transplant, by type and country of origin of donor, in 2008 28 Table 2.4b(i) Number of deceased donors, used in a transplant, by type of donor, from 2004 to 2008 28 Table 2.4b(ii) Number of deceased donors, used in a transplant, by type and country of origin of donor, in 2008 29 Table 2.4c(i) Non-heart beating donors from 2004 to 2008 29 Table 2.4c(ii) Non-heart beating donors in 2008 29 Table 2.4d(i) Transplants from NHB donors from 2004 to 2008 29 Table 2.4d(ii) Transplants from NHB donors in 2008 30 Table 2.5(i) Active Eurotransplant waiting list, by organ, as per December 31, from 2004 to 2008 30 Table 2.5(ii) Active Eurotransplant waiting list, by organ, as per December 31, 2008 31 Table 2.6(i) Registration events on the Eurotransplant waiting list, by organ from 2004 to 2008 31 Table 2.6(ii) Registration events on the Eurotransplant waiting list, by organ and country, in 2008 32 Table 2.7(i) Number of transplanted organs, by organ, by donor type, from 2004 to 2008 32 Table 2.7(ii) Number of transplanted organs, by organ, by donor type, by country of transplant, in 2008 32 Table 2.8(i) Transplants from 2004 to 2008 33 Table 2.8(ii) Transplants in 2008, by transplant country 34 Table 2.9(i) Mortality on the Eurotransplant waiting list, by date of death, from 2004 to 2008 34 Table 2.9(ii) Mortality on the Eurotransplant waiting list in 2008 34 3. Kidney: donation, waiting lists and transplants 35 Table 3.1(i) Deceased donors / kidneys in Eurotransplant, from 2004 to 2008 35 Table 3.1(ii) Deceased donors / kidneys in Eurotransplant in 2008 35 Table 3.2(i) Active kidney transplant waiting list, as per December 31, from 2004 to 2008 - characteristics 35 Table 3.2(ii) Active kidney transplant waiting list, as per December 31 , 2008 - characteristics 36 Table 3.3(i) Active kidney only transplant waiting list, as per December 31, from 2004 to 2008 - characteristics 36 Table 3.3(ii) Active kidney only transplant waiting list, as per December 31, 2008 - characteristics 36 Table 3.4(i) Kidney transplants - characteristics from 2004 to 2008 37 Table 3.4(ii) Kidney transplants - characteristics - 2008 38 Table 3.5(i) Living donor kidney transplants - kidney only - 2004 to 2008 39 Table 3.5(ii) Living donor kidney transplants - kidney only - 2008 40 Figure 3.1 Dynamics of the Eurotransplant kidney transplant waiting list and transplants between 1969 and 2008 40 4. Thoracic organs: donation, waiting lists and transplants 41 Table 4.1(i) Deceased donors / hearts in Eurotransplant from 2004 to 2008 41 Table 4.1(ii) Deceased donors / hearts in Eurotransplant in 2008 41 Table 4.2(i) Deceased donors / lungs in Eurotransplant from 2004 to 2008 41 Table 4.2(ii) Deceased donors / lungs in Eurotransplant in 2008 42 Table 4.3(i) Active heart transplant waiting list, as per December 31, from 2004 to 2008 - characteristics 42 3 Table 4.3(ii) Active heart transplant waiting list as per December 31, 2008 - characteristics 42 Table 4.4(i) Active heart only transplant waiting list as per December 31, from 2004 to 2008 - characteristics 42 Table 4.4(ii) Active heart only transplant waiting list as per December 31, 2008 - characteristics 43 Table 4.5(i) Active heart + lung transplant waiting list as per December 31, from 2004 to 2008 - characteristics 44 Table 4.5(ii) Active heart + lung transplant waiting list, as per December 31, 2008 - characteristics 44 Table 4.6(i) Active heart + lung transplant waiting list as per December 31, from 2004 to 2008 - characteristics 44 Table 4.6(ii) Active heart + lung transplant waiting list as per December 31, 2008 - characteristics 44 Table 4.7(i) Active lung transplant waiting list as per December 31, from 2004 to 2008 - characteristics 45 Table 4.7(ii) Active lung transplant waiting list as per December 31, 2008 - characteristics 45 Table 4.8(i) Active lung only transplant waiting list, as per December 31, from 2004 to 2008 - characteristics 45 Table 4.8(ii) Active lung only transplant waiting list, as per December 31, 2008 - characteristics 46 Table 4.9(i) Heart transplants from 2004 to 2008 - characteristics 46 Table 4.9(ii) Heart transplants 2008 - characteristics 47 Table 4.10(i) Heart + lung transplants from 2004 to 2008 - characteristics 48 Table 4.10(ii) Heart + lung transplants 2008 - characteristics 48 Table 4.11(i) Lung transplants from 2004 to 2008 - characteristics 49 Table 4.11(ii) Lung transplants 2008 - characteristics 50 Figure 4.1 Dynamics of the Eurotransplant heart waiting list and transplants between 1991 and 2008 50 Figure 4.2 Dynamics of the Eurotransplant heart + lung waiting list and heart + lung transplants and 50 Eurotransplant lung waiting list and lung transplants between 1991 and 2008 5. Liver and intestine: donation, waiting lists and tranplants 51 Table 5.1(i) Deceased donor livers in Eurotransplant from 2004 to 2008 51 Table 5.1(ii) Deceased donor livers in Eurotransplant in 2008 51 Table 5.2(i) Active liver transplant waiting list, as per December 31, from 2004 to 2008 - characteristics 52 Table 5.2(ii) Active liver transplant waiting list, as per December 31, 2008 - characteristics 52 Table 5.3(i) Active liver only transplant waiting list as per December 31, from 2004 to 2008 - characteristics 52 Table 5.3(ii) Active liver only transplant waiting list as per December 31, 2008 - characteristics 53 Table 5.4(i) Liver transplants from 2004 to 2008 - characteristics 54 Table 5.4(ii) Liver transplants 2008 - characteristics 54 Table 5.5(i) Living donor liver transplants - liver only - from 2004 to 2008 55 Table 5.5(ii) Living donor liver transplants - liver only - 2008 56 Figure 5.1 Dynamics of the Eurotransplant liver waiting list and liver transplants between 1991 and 2008 56 - Intestine transplants 2008 57 Table 5.6 Number of intestinal transplants performed in 2008 57 6. Pancreas and islets: donation, waiting lists and transplants 58 Table 6.1(i) Deceased donors / pancreas in Eurotransplant from 2004 to 2008 58 Table 6.1(ii) Deceased donors / pancreas in Eurotransplant in 2008 58 Table 6.2(i) Active pancreas transplant waiting list as per December 31, from 2004 to 2008 - characteristics 58 Table 6.2(ii) Active pancreas transplant waiting list as per December 31 , 2008 - characteristics 59 Table 6.3a(i) Active pancreas only transplant waiting list as per December 31, from 2004 to 2008 - characteristics 59 Table 6.3a(ii) Active pancreas only transplant waiting list as per December 31, 2008 - characteristics 59 Table 6.3b(i) Active kidney + pancreas transplant waiting list as per December 31, from 2004 to 2008 - characteristics 60 Table 6.3b(ii) Active kidney + pancreas transplant waiting list as per December 31, 2008 - characteristics 60 Table 6.4a(i) Pancreas transplants from 2004 to 2008 - characteristics 61 Table 6.4a(ii) Pancreas transplants 2008 - characteristics 62 Table 6.4b(i) Number of pancreas islet transplants from 2004 to 2008 62 Table 6.4b(ii) Number of pancreas islet transplants in 2008 62 Table 6.4c(i) Pancreas transplants from 2004 to 2008 - characteristics 62 Table 6.4c(ii) Pancreas transplants 2008 - characteristics 63 Figure 6.1 Dynamics of the Eurotransplant pancreas+kidney and islet+kidney waiting list, pancreas+kidney, islet+kidney, 63 pancreas and islet-only transplants between 1991 and 2008 7.
Load more

Recommended publications
  • Surgical Advances in Heart and Lung Transplantation
    Anesthesiology Clin N Am 22 (2004) 789–807 Surgical advances in heart and lung transplantation Eric E. Roselli, MD*, Nicholas G. Smedira, MD Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Desk F25, 9500 Euclid Avenue, Cleveland, OH 44195, USA The first heart transplants were performed in dogs by Alexis Carrel and Charles Guthrie in 1905, but it was not until the 1950s that attempts at human orthotopic heart transplant were reported. Several obstacles, including a clear definition of brain death, adequate organ preservation, control of rejection, and an easily reproducible method of implantation, slowed progress. Eventually, the first successful human to human orthotopic heart transplant was performed by Christian Barnard in South Africa in 1967 [1]. Poor healing of bronchial anastomoses hindered early progress in lung transplantation, first reported in 1963 [2]. The first successful transplant of heart and both lungs was accomplished at Stanford University School of Medicine (Stanford, CA) in 1981 [3]. The introduction of cyclosporine to immunosuppres- sion protocols, with lower doses of steroids, led to the first successful isolated lung transplant, performed at Toronto General Hospital in 1983 [4]. Since these early successes at thoracic transplantation, great progress has been made in the care of patients with end-stage heart and lung disease. Although only minor changes have occurred in surgical technique for heart and lung transplantation, the greatest changes have been in liberalizing donor criteria to expand the donor pool. This article focuses on more recent surgical advances in donor selection and management, procurement and implantation, and the impact these advances have had on patient outcome.
    [Show full text]
  • Clinical Policy: Lung Transplantation Reference Number: CP.MP.57 Coding Implications Last Review Date: 05/20 Revision Log
    Clinical Policy: Lung Transplantation Reference Number: CP.MP.57 Coding Implications Last Review Date: 05/20 Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description Medical necessity criteria for the review of lung transplantation requests. Policy/Criteria I. It is the policy of health plans affiliated with Centene Corporation® that lung transplant for members with chronic, end-stage lung disease who have failed maximal medical therapy is medically necessary when all of the following criteria are met: A. High (> 50%) risk of death from lung disease within 2 years if lung transplantation is not performed. B. High (> 80%) likelihood of surviving at least 90 days after lung transplantation. C. High (> 80%) likelihood of 5-year post-transplant survival from a general medical perspective provided that there is adequate graft function. D. Does not have ANY of the following absolute contraindications: 1. Malignancy, except for non-melanoma localized skin cancer that has been treated appropriately, low grade prostate cancer, a malignancy that has been completely resected, or a treated malignancy determined to have a small likelihood of recurrence and acceptable future risks; 2. Untreatable significant dysfunction of another major organ system unless combined organ transplantation can be performed; 3. Uncorrected atherosclerotic disease with suspected or confirmed end-organ ischemia or dysfunction and/or coronary artery disease not amenable to revascularization; 4. Acute medical instability, including, but not limited to, acute sepsis, acute viral respiratory infection, myocardial infarction, and liver failure; 5. Uncorrectable bleeding diathesis; 6. Chronic infection with highly virulent and/or resistant microbes that are poorly controlled pre-transplant; 7.
    [Show full text]
  • Lung Transplantation with the OCS (Organ Care System)
    Lung Transplantation with the OCSTM (Organ Care System) Lung System Bringing Breathing Lung Preservation to Transplant Patients A Guide for You and Your Family DRAFT ABOUT THIS BOOKLET This booklet was created for patients like you who have been diagnosed with end-stage lung failure and are candidates for a lung transplant. It contains information that will help you and your family learn about options available to you for a transplant. This booklet includes information on your lungs, how they function, and respiratory failure. In addition, you will learn about a new way to preserve lungs before transplantation, called breathing lung preservation. Your doctor is the best person to explain your treatment options and their risks and to help you decide which option is right for you. The booklet explains: • Breathing lung preservation with the OCS™ Lung System • How the OCS™ Lung System works • Who is eligible for the OCS™ Lung System • Lung transplant complications • How the lungs function • What is respiratory failure and the treatment options • What to expect during your treatment • Summary of clinical data for the OCS™ Lung System • Contact Information Please read this booklet carefully and share it with your family and caregivers. For your convenience, a glossary is provided in the front of this booklet. Terms in the text in bold italics are explained in the glossary. If you have questions about the OCS™ Lung System that are not answered in this booklet, please ask your physician. This booklet is intended for general information only. It is not intended to tell you everything you need to know about a lung transplant.
    [Show full text]
  • The History of the First Kidney Transplantation
    165+3 14 mm "Service to society is the rent we pay for living on this planet" The History of the Joseph E. Murray, 1990 Nobel-laureate who performed the first long-term functioning kidney transplantation in the world First Kidney "The pioneers sacrificed their scientific life to convince the medical society that this will become sooner or later a successful procedure… – …it is a feeling – now I am Transplantation going to overdo - like taking part in creation...” András Németh, who performed the first – a European Overview Hungarian renal transplantation in 1962 E d i t e d b y : "Professor Langer contributes an outstanding “service” to the field by a detailed Robert Langer recording of the history of kidney transplantation as developed throughout Europe. The authoritative information is assembled country by country by a generation of transplant professionals who knew the work of their pioneer predecessors. The accounting as compiled by Professor Langer becomes an essential and exceptional reference document that conveys the “service to society” that kidney transplantation has provided for all mankind and that Dr. Murray urged be done.” Francis L. Delmonico, M.D. Professor of Surgery, Harvard Medical School, Massachusetts General Hospital Past President The Transplantation Society and the Organ Procurement Transplant Network (UNOS) Chair, WHO Task Force Organ and Tissue Donation and Transplantation The History of the First Kidney Transplantation – a European Overview European a – Transplantation Kidney First the of History The ISBN 978-963-331-476-0 Robert Langer 9 789633 314760 The History of the First Kidney Transplantation – a European Overview Edited by: Robert Langer SemmelweisPublishers www.semmelweiskiado.hu Budapest, 2019 © Semmelweis Press and Multimedia Studio Budapest, 2019 eISBN 978-963-331-473-9 All rights reserved.
    [Show full text]
  • Newsletteralumni News of the Newyork-Presbyterian Hospital/Columbia University Department of Surgery Volume 13, Number 1 Summer 2010
    NEWSLETTERAlumni News of the NewYork-Presbyterian Hospital/Columbia University Department of Surgery Volume 13, Number 1 Summer 2010 CUMC 2007-2009 Transplant Activity Profile* Activity Kidney Liver Heart Lung Pancreas Baseline list at year start 694 274 174 136 24 Deceased donor transplant 123 124 93 57 11 Living donor transplant 138 17 — 0 — Transplant rate from list 33% 50% 51% 57% 35% Mortality rate while on list 9% 9% 9% 15% 0% New listings 411 217 144 68 23 Wait list at year finish 735 305 204 53 36 2007-June 2008 Percent 1-Year Survival No % No % No % No % No % Adult grafts 610 91 279 86 169 84 123 89 6 100 Adult patients 517 96 262 88 159 84 116 91 5 100 Pediatric grafts 13 100 38 86 51 91 3 100 0 — Pediatric patients 11 100 34 97 47 90 2 100 0 — Summary Data Total 2009 living donor transplants 155 (89% Kidney) Total 2009 deceased donor transplants 408 (30% Kidney, 30% Liver) 2007-June 2008 adult 1-year patient survival range 84% Heart to 100% Pancreas 2007-June 2008 pediatric 1-year patient survival range 90% Heart to 100% Kidney or lung *Health Resource and Service Administration’s Scientific Registry of Transplant Recipients (SRTR) Ed Note. The figure shows the US waiting list for whole organs which will only be partially fulfilled by some 8,000 deceased donors, along with 6,600 living donors, who will provide 28,000 to 29,000 organs in 2010. The Medical Center’s role in this process is summarized in the table, and the articles that follow my note expand on this incredible short fall and its potential solutions.
    [Show full text]
  • Organ Transplant Discrimination Against People with Disabilities Part of the Bioethics and Disability Series
    Organ Transplant Discrimination Against People with Disabilities Part of the Bioethics and Disability Series National Council on Disability September 25, 2019 National Council on Disability (NCD) 1331 F Street NW, Suite 850 Washington, DC 20004 Organ Transplant Discrimination Against People with Disabilities: Part of the Bioethics and Disability Series National Council on Disability, September 25, 2019 This report is also available in alternative formats. Please visit the National Council on Disability (NCD) website (www.ncd.gov) or contact NCD to request an alternative format using the following information: [email protected] Email 202-272-2004 Voice 202-272-2022 Fax The views contained in this report do not necessarily represent those of the Administration, as this and all NCD documents are not subject to the A-19 Executive Branch review process. National Council on Disability An independent federal agency making recommendations to the President and Congress to enhance the quality of life for all Americans with disabilities and their families. Letter of Transmittal September 25, 2019 The President The White House Washington, DC 20500 Dear Mr. President, On behalf of the National Council on Disability (NCD), I am pleased to submit Organ Transplants and Discrimination Against People with Disabilities, part of a five-report series on the intersection of disability and bioethics. This report, and the others in the series, focuses on how the historical and continued devaluation of the lives of people with disabilities by the medical community, legislators, researchers, and even health economists, perpetuates unequal access to medical care, including life- saving care. Organ transplants save lives. But for far too long, people with disabilities have been denied organ transplants as a result of unfounded assumptions about their quality of life and misconceptions about their ability to comply with post-operative care.
    [Show full text]
  • Cooperating Saves Lives Start Contents
    Annual Report 2019 Cooperating saves lives start contents Contents Foreword 1. The Eurotransplant community 2. Eurotransplant: donation, allocation, transplantation and waiting lists This document is optimized for Acrobat Reader for best viewing 3. Report of the Board and the central office experience. 4. Histocompatibility Testing Download Acrobat Reader 5. Reporting of non-resident transplants in Eurotransplant 6. Transplant programs and their delegates in 2019 A high resolution version of this document is also available. 7. Scientific output in 2019 Download high resolution pdf 8. Eurotransplant personnel related statistics 9. Abbreviated financial statements All rights reserved. No part of this publication may be reproduced, stored in a retrieval system List of abbreviations or transmitted, in any form or by any means, electronic, mechanical, photocopying or elsewise, without prior permission of Eurotransplant. For permissions, please contact: [email protected] start contents Foreword Dear reader, We are proud to offer you the 2019, digital edition of the International organ exchange Eurotransplant Annual Report. In this environmentally In 2019, 6981 organs from 2042 deceased donors were friendly, digital report you can easily browse via the used for transplantation for patients on the waiting top menu. Weblinks are added to facilitate in finding list of Eurotransplant. This decrease of the number of more specific information on relevant websites. The reported donors is 5,5% compared to 2018 (2159). report provides an overview of the key statistics on 21.5% of organs were exchanged cross-border between organ donation, allocation and transplantation in all the Eurotransplant member states. Thanks to this Eurotransplant countries. international exchange, a suitable donor organ could be You can also read in the report activities within found for many patients in the different Eurotransplant Eurotransplant that took place, decisions that were member states.
    [Show full text]
  • The Story of Organ Transplantation, 21 Hastings L.J
    Hastings Law Journal Volume 21 | Issue 1 Article 4 1-1969 The tS ory of Organ Transplantation J. Englebert Dunphy Follow this and additional works at: https://repository.uchastings.edu/hastings_law_journal Part of the Law Commons Recommended Citation J. Englebert Dunphy, The Story of Organ Transplantation, 21 Hastings L.J. 67 (1969). Available at: https://repository.uchastings.edu/hastings_law_journal/vol21/iss1/4 This Article is brought to you for free and open access by the Law Journals at UC Hastings Scholarship Repository. It has been accepted for inclusion in Hastings Law Journal by an authorized editor of UC Hastings Scholarship Repository. The Story of Organ Transplantation By J. ENGLEBERT DUNmHY, M.D.* THE successful transplantation of a heart from one human being to another, by Dr. Christian Barnard of South Africa, hias occasioned an intense renewal of public interest in organ transplantation. The back- ground of transplantation, and its present status, with a note on certain ethical aspects are reviewed here with the interest of the lay reader in mind. History of Transplants Transplantation of tissues was performed over 5000 years ago. Both the Egyptians and Hindus transplanted skin to replace noses destroyed by syphilis. Between 53 B.C. and 210 A.D., both Celsus and Galen carried out successful transplantation of tissues from one part of the body to another. While reports of transplantation of tissues from one person to another were also recorded, accurate documentation of success was not established. John Hunter, the father of scientific surgery, practiced transplan- tation experimentally and clinically in the 1760's. Hunter, assisted by a dentist, transplanted teeth for distinguished ladies, usually taking them from their unfortunate maidservants.
    [Show full text]
  • Methods I N Molecular Biology
    M ETHODS IN M OLECULAR B IOLOGY Series Editor John M. Walker School of Life and Medical Sciences University of Hertfordshire Hatfield, Hertfordshire, AL10 9AB, UK For further volumes: http://www.springer.com/series/7651 HLA Typing Methods and Protocols Edited by Sebastian Boegel Johannes Gutenberg University of Mainz, Mainz, Germany Editor Sebastian Boegel Johannes Gutenberg University of Mainz Mainz, Germany ISSN 1064-3745 ISSN 1940-6029 (electronic) Methods in Molecular Biology ISBN 978-1-4939-8545-6 ISBN 978-1-4939-8546-3 (eBook) https://doi.org/10.1007/978-1-4939-8546-3 Library of Congress Control Number: 2018943706 © Springer Science+Business Media, LLC, part of Springer Nature 2018 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made.
    [Show full text]
  • Analysis of the Trend Over Time of High-Urgency Liver Transplantation Requests in Italy in the 4-Year Period 2014-2017
    Analysis of the Trend Over Time of High-Urgency Liver Transplantation Requests in Italy in the 4-Year Period 2014-2017 S. Trapani*, F. Puoti, V. Morabito, D. Peritore, P. Fiaschetti, A. Oliveti, M. Caprio, L. Masiero, L. Rizzato, L. Lombardini, A. Nanni Costa, and M. Cardillo Italian National Transplant Center, Italian Institute of Health, Rome, Italy ABSTRACT Background. The national protocol for the handling of high-urgency (HU) liver organ procurement for transplant is administered by the Italian National Transplant Center. In recent years, we have witnessed a change in requests to access the program. We have therefore evaluated their temporal trend, the need to change the access criteria, the percentage of transplants performed, the time of request satisfaction, and the follow-up. Methods. We analyzed all the liver requests for the HU program received during the 4-year period of 2014 to 2017 for adult recipients (18 years of age): all the variables linked to the recipient or to the donor and the organ transplants are registered in the Informative Transplant System as established by the law 91/99. In addition, intention to treat (ITT) survival rates were compared among 4 different groups: (1) patients on standard waiting lists vs (2) patients on urgency waiting lists, and (3) patients with a history of transplant in urgency vs (4) patients with a history of transplant not in urgency. Results. Out of the 370 requests included in the study, 291 (78.7%) were satisfied with liver transplantation. Seventy-nine requests (21.3%) have not been processed, but if we consider only the real failures, this percentage falls to 13.1% and the percentage of satisfied requests rises to 86.9%.
    [Show full text]
  • Chronic Lung Allograft Dysfunction Post Lung Transplantation: a Review of Computed Tomography Quantitative Methods for Detection and Follow-Up
    Journal of Clinical Medicine Review Chronic Lung Allograft Dysfunction Post Lung Transplantation: A Review of Computed Tomography Quantitative Methods for Detection and Follow-Up Trieu-Nghi Hoang-Thi 1,2,3 , Guillaume Chassagnon 1, Thong Hua-Huy 3, Veronique Boussaud 4, Anh-Tuan Dinh-Xuan 3 and Marie-Pierre Revel 1,* 1 AP-HP.Centre, Hôpital Cochin, Department of Radiology, Université de Paris, 75014 Paris, France; [email protected] (T.-N.H.-T.); [email protected] (G.C.) 2 Department of Diagnostic Imaging, Vinmec Central Park Hospital, Ho Chi Minh City 70000, Vietnam 3 AP-HP.Centre, Hôpital Cochin, Department of Respiratory Physiology, Université de Paris, 75014 Paris, France; [email protected] (T.H.-H.); [email protected] (A.-T.D.-X.) 4 AP-HP.Centre, Hôpital Cochin, Department of Pneumology, Université de Paris, 75014 Paris, France; [email protected] * Correspondence: [email protected]; Tel.: +33-1-5841-2471 Abstract: Chronic lung allograft dysfunction (CLAD) remains the leading cause of morbidity and mortality after lung transplantation. The term encompasses both obstructive and restrictive pheno- types, as well as mixed and undefined phenotypes. Imaging, in addition to pulmonary function tests, plays a major role in identifying the CLAD phenotype and is essential for follow-up after Citation: Hoang-Thi, T.-N.; lung transplantation. Quantitative imaging allows for the performing of reader-independent precise Chassagnon, G.; Hua-Huy, T.; Boussaud, V.; Dinh-Xuan, A.-T.; evaluation of CT examinations. In this review article, we will discuss the role of quantitative imaging Revel, M.-P.
    [Show full text]
  • Spain, France and Italy Are to Exchange Organs for Donation Chains
    Translation of an article published in the Spanish newspaper ABC on 10 October 2012 O.J.D.: 201504 Date: 10/10/2012 E.G.M.: 641000 Section: SOCIETY Pages: 38, 39 ----------------------------------------------------------------------------------------------------------------- This is what happened in Spain’s first ‘crossover’ transplant [For diagram see original article] Altruistic donor The chain started with the kidney donation from a ‘good Samaritan’ going to a recipient in a couple. The wife of the first recipient donated her kidney to a sick person in a second couple. The wife of the second recipient donated her kidney to a third patient on the waiting list. On the waiting list The final recipient, selected using medical criteria, was on the waiting list to receive a kidney from a deceased donor for three years. Spain, France and Italy are to exchange organs for donation chains ► The creation of this type of ‘common area’ in southern Europe will increase the chances of finding a donor match CRISTINA GARRIDO BRUSSELS | Stronger together. Although there are many things on which we find it difficult to agree, this time the strategy was clear. Spain, France and Italy have signed the Southern Europe Transplant Alliance to promote their successful donation and transplant system – which is public, coordinated and directly answerable to the Ministries of Health, as compared to the private models of central and northern Europe – to the international bodies. ‘We (Spain, France and Italy) decided that we had to do something together because we have similar philosophies, ethical criteria and structures and we could not each go our own way given how things are in the northern countries’, explained Dr Rafael Matesanz, Director of the Spanish National Transplant Organisation, at the seminar on donations and transplants organised by the European Commission in Brussels yesterday.
    [Show full text]